Background Most patients with an exacerbation of chronic obstructive pulmonary disease (COPD)
are treated with antibiotics. However the value of their use remains uncertain. Some …

Recommendations in asthma guidelines presuppose that practitioners have the evidence,
information, knowledge, and tools to select inhaler devices appropriate for individual patients. …

… Barnes, unpublished data) suggest that hot extraction … Barnes, unpublished data). This
may have been the case for the tofu … G.; Barnes, S. Genistein inhibition of the grown of human …

Significant cardiac morbidity and mortality exists in patients with COPD. Shared risk factors
include age, smoking history and exposure to air pollution and passive smoke. Although the …

In order to determine whether the airway inflammatory cells of chronic obstructive pulmonary
disease (COPD) are different from those seen in asthma, we have studied a subepithelial …

Rationale: Accumulation of eosinophils in the bronchial mucosa of individuals with asthma
is considered to be a central event in the pathogenesis of asthma. In animal models, airway …

Background The short-term benefits of inhaled corticosteroids for patients with chronic
obstructive pulmonary disease (COPD) are greater in patients with evidence of eosinophilic …

Rationale: No currently available treatment is reported to reduce the exaggerated airway
wall inflammation of chronic obstructive pulmonary disease. Objectives: We tested the …

Objective We performed a review of studies of fluticasone propionate (FP)/salmeterol (SAL) (combination
inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA)) in patients with …

Inhaled corticosteroids (ICS) are effective in the treatment of asthma and markedly reduce
the numbers of inflammatory cells in bronchial biopsies. However, the effect of ICS on the …